What does the evidence say about Green-Lipped Mussel Joint Function Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Green-Lipped Mussel Joint Function Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - Background Knee osteoarthritis (OA) is a prevalent degenerative joint disease associated with pain, functional limitation, and reduced quality of life. [Kim HT (2026); evidence level 2] - Significant between-group differences were also observed for WOMAC pain (p = 0.026), WOMAC physical function (p = 0.027), and VAS pain (between-group difference - 19.93 mm; 95% CI - 25.31 to - 14.55; p Conclusions Twelve-week supplementation with GLMP was associated with improvements in pain and physical function in adults with mild-to-moderate knee OA. [Kim HT (2026); evidence level 2] - Although nonsteroidal anti-inflammatory drugs are widely prescribed, long-term use is limited by safety concerns. [Kim HT (2026); evidence level 2] - Fucoidan, an extract from seaweed Undaria pinnatifida , has been found to have beneficial effects on joint pain and insulin resistance. [Tay A (2022); evidence level 2] - Introduction Pharmaceutical drugs are beneficial to inflammatory conditions but with side effects, which led to the search for alternative therapies. [Tay A (2022); evidence level 2] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.